VTRS · Viatris Inc
$16.23
+0.19 (+1.18%)
At close · Aug 14
Market Cap
$18.64B
Shares
1.15B
Viatris Inc Earnings Call Transcripts
Every quarterly earnings call for Viatris Inc (VTRS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼10.1%
$4.08B
'22 Q3
22-11-07
▼10.7%
$3.88B
'22 Q4
23-02-27
▼11%
$3.73B
'23 Q1
23-05-08
▼4.8%
$3.92B
'23 Q2
23-08-07
▼3.3%
$3.94B
'23 Q3
23-11-07
▼1%
$3.84B
'23 Q4
24-02-28
▼1.8%
$3.66B
'24 Q1
24-05-09
▼3.1%
$3.80B
'24 Q2
24-08-08
▼4.8%
$3.75B
'24 Q3
24-11-07
▼8.1%
$3.53B
'24 Q4
25-02-27
▼11.2%
$3.25B
'25 Q1
25-05-08
▼5.6%
$3.58B
'25 Q2
25-08-07
▲0.2%
$3.76B
'25 Q3
25-11-06
▲5%
$3.70B
'25 Q4
26-02-26
▲8.1%
$3.52B
'26 Q1
26-05-07
LATEST
▲4.9%
$3.76B
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Viatris Inc Q2 FY2026 Earnings Call
Confident tone
Pipeline and regulatory catalysts
Estradiol patch / transdermal opportunity
Complex generics pipeline
Revenue
$3.76B
▲ 4.9% YoY Diluted EPS
$-0.10
Gross margin
38.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Viatris Inc Q1 FY2026 Earnings Call
Confident tone
Greater China and Japan commercial execution
GLP-1 generic strategy
Pipeline and product launches
Revenue
$3.52B
▲ 8.1% YoY Diluted EPS
$0.15
Gross margin
32.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Viatris Inc Q4 FY2025 Earnings Call
Confident tone
Product Launches
Pipeline and R&D
Strategic Review and Cost Savings
Revenue
$3.70B*
▲ 5% YoY Gross margin
31.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Viatris Inc Q3 FY2025 Earnings Call
Confident tone
Pipeline and R&D advancement
2026 outlook and new product revenue
Commercial performance across regions
Revenue
$3.76B
▲ 0.2% YoY Diluted EPS
$-0.11
▼ 237.5% YoY Gross margin
36.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Viatris Inc Q2 FY2025 Earnings Call
Confident tone
Eye Care division / ophthalmology
Late-stage pipeline and innovation
Q2 operational and financial performance
Revenue
$3.58B
▼ 5.6% YoY Diluted EPS
$0.00
Gross margin
37.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Viatris Inc Q1 FY2025 Earnings Call
Positive tone
Pipeline progress and Phase 3 readouts
Indore facility remediation
Capital returns to shareholders
Revenue
$3.25B
▼ 11.2% YoY Diluted EPS
$-2.55
▼ 2933.3% YoY Gross margin
35.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Viatris Inc Q4 FY2024 Earnings Call
Balanced tone
Indore FDA remediation and import alert
Innovative pipeline and Phase 3 readouts
Idorsia collaboration restructuring
Revenue
$3.53B*
▼ 8.1% YoY Gross margin
34.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Viatris Inc Q3 FY2024 Earnings Call
Confident tone
Capital allocation and shareholder returns
Operational revenue growth and base business momentum
Financial performance and profitability
Revenue
$3.75B
▼ 4.8% YoY Diluted EPS
$0.08
▼ 70.4% YoY Gross margin
38.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Viatris Inc Q2 FY2024 Earnings Call
Positive tone
Innovative pipeline and R&D strategy
Divestitures and portfolio simplification
Financial strength and capital return
Revenue
$3.80B
▼ 3.1% YoY Diluted EPS
$-0.27
▼ 222.7% YoY Gross margin
38.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Viatris Inc Q1 FY2024 Earnings Call
Confident tone
Idorsia assets and trial expansion
New product revenue
Execution and 2024 guidance
Revenue
$3.66B
▼ 1.8% YoY Diluted EPS
$0.09
▼ 52.6% YoY Gross margin
41.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Viatris Inc Q4 FY2023 Earnings Call
Confident tone
2024 Guidance and Capital Allocation
Idorsia R&D Collaboration
2023 Full-Year Financial Results
Revenue
$3.84B*
▼ 1% YoY Gross margin
41.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Viatris Inc Q3 FY2023 Earnings Call
Revenue
$3.94B
▼ 3.3% YoY Diluted EPS
$0.27
▼ 6.9% YoY Gross margin
42.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Viatris Inc Q2 FY2023 Earnings Call
Revenue
$3.92B
▼ 4.8% YoY Diluted EPS
$0.22
▼ 15.4% YoY Gross margin
41.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Viatris Inc Q1 FY2023 Earnings Call
Revenue
$3.73B
▼ 11% YoY Diluted EPS
$0.19
▼ 42.4% YoY Gross margin
41.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-27
Viatris Inc Q4 FY2022 Earnings Call
Revenue
$3.88B*
▼ 10.7% YoY Gross margin
32.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Viatris Inc Q3 FY2022 Earnings Call
Revenue
$4.08B
▼ 10.1% YoY Diluted EPS
$0.29
▲ 11.5% YoY Gross margin
42.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Viatris Inc Q2 FY2022 Earnings Call
Revenue
$4.12B
▼ 10.1% YoY Diluted EPS
$0.26
Gross margin
41.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Viatris Inc Q1 FY2022 Earnings Call
Revenue
$4.19B
▼ 5.4% YoY Diluted EPS
$0.33
Gross margin
42.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
Viatris Inc Q4 FY2021 Earnings Call
Revenue
$4.34B*
▲ 19.8% YoY Gross margin
35.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q2
2021-08-09
Viatris Inc Q2 FY2021 Earnings Call
Revenue
$4.58B
▲ 67.6% YoY Diluted EPS
$-0.23
▼ 387.5% YoY Gross margin
29.0%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Viatris Inc Q1 FY2021 Earnings Call
Revenue
$4.43B
▲ 69.1% YoY Diluted EPS
$-0.86
▼ 2250% YoY Gross margin
25.4%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-22
Viatris Inc Q4 FY2020 Earnings Call
Revenue
$3.62B*
Gross margin
19.5%
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Showing 1–22 of 22 earnings calls
Key facts
CIK
1792044
CUSIP
92556V106
13F (30d)
921 filings
872 filers
Visit website
Investor relations